Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting

Author's Avatar
Mar 08, 2022

Company to present late-breaking clinical trial update for TiTAN trial of GEN-011, Genocea’s neoantigen-targeted peripheral T cell therapy for solid tumors